# EDGAR Filing Document

**Accession Number:** 0001633061
**File Stem:** 0001193125-26-241555
**Filing Date:** 2026-5
**Character Count:** 10521
**Document Hash:** 6e3b49e649dfc1547f38e893c60e175c
**Contains OCR:** False
**Source Format:** 

## Filing Content

## Filing Summary
**0001193125-26-241555.hdr.sgml**: 20260527

**ACCESSION NUMBER**: 0001193125-26-241555

**CONFORMED SUBMISSION TYPE**: NPORT-P

**PUBLIC DOCUMENT COUNT**: 1

**CONFORMED PERIOD OF REPORT**: 20260331

**FILED AS OF DATE**: 20260527

**DATE AS OF CHANGE**: 20260527

**PERIOD START**: 20260930

**FILER**: 

**COMPANY DATA:**
- **COMPANY CONFORMED NAME:** Amplify ETF Trust
- **CENTRAL INDEX KEY:** 0001633061

**ORGANIZATION NAME:**
- **EIN:** 000000000
- **STATE OF INCORPORATION:** MA
- **FISCAL YEAR END:** 1231

**FILING VALUES:**
- **FORM TYPE:** NPORT-P
- **SEC ACT:** 1940 Act
- **SEC FILE NUMBER:** 811-23108
- **FILM NUMBER:** 261025416

**BUSINESS ADDRESS:**
- **STREET 1:** 3333 WARRENVILLE ROAD
- **STREET 2:** SUITE 350
- **CITY:** LISLE
- **STATE:** IL
- **ZIP:** 60532
- **BUSINESS PHONE:** (855)267-3837

**MAIL ADDRESS:**
- **STREET 1:** 3333 WARRENVILLE ROAD
- **STREET 2:** SUITE 350
- **CITY:** LISLE
- **STATE:** IL
- **ZIP:** 60532

## Series and Classes Contracts Data

### Amplify Weight Loss Drug & Treatment ETF (Series ID: S000085024)

| Class ID   | Class Name                               | Ticker Symbol   |
|:---|:---|:---|
| C000249887 | Amplify Weight Loss Drug & Treatment ETF |  |

## Form NPORT-P: Monthly Portfolio Investments Report

### NPORT-P: Part A: General Information

**Item A.1. Information about the Registrant.**

- **a. Name of Registrant:** Amplify ETF Trust

- **b. Investment Company Act file number:** 811-23108

- **c. CIK number of Registrant:** 0001633061

- **d. LEI of Registrant:** 5493006EMX6222CPWJ71

- **e. Address and telephone number of Registrant.**

  - **Street Address 1:** 3333 Warrenville Road

  - **City:** Lisle

  - **State:** IL

  - **Foreign country:** US

  - **Zip / Postal Code:** 60532

  - **Telephone number:** 855-267-3837

**Item A.2. Information about the Series.**

- **a. Name of Series:** Amplify Weight Loss Drug & Treatment ETF

- **b. EDGAR series identifier (if any):** S000085024

- **c. LEI of Series:** 52990078J44DANY0H471

**Item A.3. Reporting period.**

- **a. Date of fiscal year-end:** 2026-09-30

- **b. Date as of which information is reported:** 2026-03-31

**Item A.4. Final filing**

Does the Fund anticipate that this will be its final filing on Form N-PORT? **No**

### Fund Information

**Total Assets:** $4156815.50

**Total Liabilities:** $4921.86

**Net Assets:** $4151893.64

**Cash Not Reported:** $2660.48

**Monthly Return Information**

| Class               | Month 1 Return (%)   | Month 2 Return (%)   | Month 3 Return (%)   |
|:---|:---|:---|:---|
| Class ID C000249887 | 3.97%                | -0.84%               | -5.95%               |

**Monthly Gains & Losses**

| Period   | Net Realized Gain/Loss   | Net Unrealized Appreciation/Depreciation   |
|:---|:---|:---|
| Month 1  | $-169.82                 | $128233.75                                 |
| Month 2  | $9.13                    | $-37153.21                                 |
| Month 3  | $-84287.53               | $-200106.22                                |

**Designated Index Information**

- **Index Name:** N/A

- **Index Identifier:** N/A

### Schedule of Portfolio Investments

| Name                           | Title                                  | Identifiers                                   | Payoff Profile   | Asset Category   | Issuer Category   | Country   |   Balance | Units   | Value (USD)   | % of Net Assets   | Maturity Date   | Coupon Type   | Annualized Rate (%)   | Restricted?   |   Fair Value Level | Lending Status   |
|:---|:---|:---|:---|:---|:---|:---|---:|:---|:---|:---|:---|:---|:---|:---|---:|:---|
| AbbVie Inc                     | AbbVie Inc                             | CUSIP: 00287Y109<br>LEI: FR5LCKFTG8054YNNRU85 | Long             | EC               | CORP              | US        |       907 | NS      | $197263.43    | 4.75%             |  |  |  | No            |                  1 | On Loan: No      |
| Amgen Inc                      | Amgen Inc                              | CUSIP: 031162100<br>LEI: 62QBXGPJ34PQ72Z12S66 | Long             | EC               | CORP              | US        |       740 | NS      | $260369.00    | 6.27%             |  |  |  | No            |                  1 | On Loan: No      |
| Arrowhead Pharmaceuticals Inc  | Arrowhead Pharmaceuticals Inc          | CUSIP: 04280A100<br>LEI: 549300O3CSB8T7OZ3D66 | Long             | EC               | CORP              | US        |      3287 | NS      | $206094.90    | 4.96%             |  |  |  | No            |                  1 | On Loan: No      |
| Eli Lilly & Co                 | Eli Lilly & Co                         | CUSIP: 532457108<br>LEI: FRDRIPF3EKNDJ2CQJL29 | Long             | EC               | CORP              | US        |       522 | NS      | $480119.94    | 11.56%            |  |  |  | No            |                  1 | On Loan: No      |
| CSPC Pharmaceutical Group Ltd  | CSPC Pharmaceutical Group Ltd          | CUSIP: N/A<br>LEI: 529900M3XQCW234H8O91       | Long             | EC               | CORP              | CN        |    180000 | NS      | $208923.24    | 5.03%             |  |  |  | No            |                  1 | On Loan: No      |
| Chugai Pharmaceutical Co Ltd   | Chugai Pharmaceutical Co Ltd           | CUSIP: N/A<br>LEI: 529900T9LAII161DCN95       | Long             | EC               | CORP              | JP        |      4600 | NS      | $248982.34    | 6.00%             |  |  |  | No            |                  1 | On Loan: No      |
| Invesco Government & Agency Po | Invesco Government & Agency Portfolio  | CUSIP: 825252885<br>LEI: 5493007T1J7WZ5QI1A47 | Long             | STIV             | RF                | US        |    123112 | NS      | $123112.50    | 2.97%             |  |  |  | No            |                  1 | On Loan: No      |
| Hanmi Pharm Co Ltd             | Hanmi Pharm Co Ltd                     | CUSIP: N/A<br>LEI: 988400PP10VZVUOFE672       | Long             | EC               | CORP              | KR        |       158 | NS      | $53125.71     | 1.28%             |  |  |  | No            |                  1 | On Loan: No      |
| Innovent Biologics Inc         | Innovent Biologics Inc                 | CUSIP: N/A<br>LEI: 25490058ONL9SCIE1R22       | Long             | EC               | CORP              | CN        |     17000 | NS      | $184089.69    | 4.43%             |  |  |  | No            |                  1 | On Loan: No      |
| AstraZeneca PLC                | AstraZeneca PLC                        | CUSIP: N/A<br>LEI: PY6ZZQWO2IZFZC3IOL08       | Long             | EC               | CORP              | GB        |       980 | NS      | $193275.60    | 4.66%             |  |  |  | No            |                  1 | On Loan: No      |
| Merck & Co Inc                 | Merck & Co Inc                         | CUSIP: 58933Y105<br>LEI: 4YV9Y5M8S0BRK1RP0397 | Long             | EC               | CORP              | US        |      1546 | NS      | $185968.34    | 4.48%             |  |  |  | No            |                  1 | On Loan: No      |
| Novo Nordisk A/S               | Novo Nordisk A/S                       | CUSIP: 670100205<br>LEI: 549300DAQ1CVT6CXN342 | Long             | EC               | CORP              | DK        |     13431 | NS      | $493589.25    | 11.89%            |  |  |  | No            |                  1 | On Loan: No      |
| Shionogi & Co Ltd              | Shionogi & Co Ltd                      | CUSIP: N/A<br>LEI: 35380049VXDTHZI3DY35       | Long             | EC               | CORP              | JP        |      8500 | NS      | $185344.77    | 4.46%             |  |  |  | No            |                  1 | On Loan: No      |
| Pfizer Inc                     | Pfizer Inc                             | CUSIP: 717081103<br>LEI: 765LHXWGK1KXCLTFYQ30 | Long             | EC               | CORP              | US        |      6828 | NS      | $191730.24    | 4.62%             |  |  |  | No            |                  1 | On Loan: No      |
| Regeneron Pharmaceuticals Inc  | Regeneron Pharmaceuticals Inc          | CUSIP: 75886F107<br>LEI: 549300RCBFWIRX3HYQ56 | Long             | EC               | CORP              | US        |       364 | NS      | $281240.96    | 6.77%             |  |  |  | No            |                  1 | On Loan: No      |
| Scholar Rock Holding Corp      | Scholar Rock Holding Corp              | CUSIP: 80706P103<br>LEI: 549300Z1FLPGL4OWJ459 | Long             | EC               | CORP              | US        |      2005 | NS      | $98565.80     | 2.37%             |  |  |  | No            |                  1 | On Loan: No      |
| Structure Therapeutics Inc     | Structure Therapeutics Inc             | CUSIP: 86366E106<br>LEI: N/A                  | Long             | EC               | CORP              | US        |      1738 | NS      | $83771.60     | 2.02%             |  |  |  | No            |                  1 | On Loan: No      |
| Viking Therapeutics Inc        | Viking Therapeutics Inc                | CUSIP: 92686J106<br>LEI: 529900IVC72YPFA25M37 | Long             | EC               | CORP              | US        |      2818 | NS      | $91697.72     | 2.21%             |  |  |  | No            |                  1 | On Loan: No      |
| Zealand Pharma A/S             | Zealand Pharma A/S                     | CUSIP: N/A<br>LEI: 549300ITBB1ULBL4CZ12       | Long             | EC               | CORP              | DK        |      1584 | NS      | $72051.07     | 1.74%             |  |  |  | No            |                  1 | On Loan: No      |
| Jiangsu Hengrui Pharmaceutical | Jiangsu Hengrui Pharmaceuticals Co Ltd | CUSIP: N/A<br>LEI: 2549003BT1XS3SE3E448       | Long             | EC               | CORP              | CN        |      6200 | NS      | $51006.35     | 1.23%             |  |  |  | No            |                  1 | On Loan: No      |
| Roche Holding AG               | Roche Holding AG                       | CUSIP: N/A<br>LEI: 549300U41AUUVOAAOB37       | Long             | EC               | CORP              | CH        |       473 | NS      | $185244.35    | 4.46%             |  |  |  | No            |                  1 | On Loan: No      |

### Signature

**Date Signed:** 2026-05-13

**Name of Applicant:** Amplify ETF Trust

**Signature:** /s/ Bradley H. Bailey

**Name of Signer:** Amplify ETF Trust

**Title:** Principal Financial Officer